|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current assets | ||||||||
| Cash | ||||||||
| Deferred offering costs | ||||||||
| Prepaid expenses | ||||||||
| Total Current Assets | ||||||||
| FPA Assets | ||||||||
| Investments held in Trust Account | ||||||||
| TOTAL ASSETS | ||||||||
| LIABILITIES, ORDINARY SHARES SUBJECT TO REDEMPTION AND SHAREHOLDERS' DEFICIT | ||||||||
| Current liabilities | ||||||||
| Accrued expenses | ||||||||
| Accounts payable and accrued expenses | ||||||||
| Accrued offering costs | ||||||||
| Promissory note – related party | ||||||||
| Total Current Liabilities | ||||||||
| FPA liabilities | ||||||||
| Warrant liabilities | ||||||||
| Deferred underwriting fee payable | ||||||||
| TOTAL LIABILITIES | ||||||||
| Class A ordinary shares subject to possible redemption, 60,000,000 shares at approximately $10.02 and $10.00, per share redemption value as of June 30, 2022 and December 31, 2021, respectively | ||||||||
| Shareholders' Deficit | ||||||||
| Ordinary shares | ||||||||
| Class A Ordinary Share | ||||||||
| Class B Ordinary Share | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ||||||||
| Class A Ordinary Share | ||||||||
| Class B Ordinary Share | ||||||||
| Total Shareholders' Deficit | ||||||||
| TOTAL LIABILITIES, ORDINARY SHARES SUBJECT TO REDEMPTION AND SHAREHOLDERS' DEFICIT |
Loading...
